Author: admin

NEW YORK, Jan. 21, 2025 /PRNewswire/ — Pomerantz LLP announces that a class action lawsuit has been filed against Regeneron Pharmaceuticals, Inc. (“Regeneron” or the “Company”) (NASDAQ: REGN). Such investors are advised to contact Danielle Peyton at [email protected]

Magazine made for you.

Featured:

No posts were found for provided query parameters.

Elsewhere: